Close

Lilly To Participate In Morgan Stanley Global Healthcare Conference

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Related stories

UCB Reports New EADV Data on Bimekizumab Treatment in HS

UCB has announced new three-year data for bimekizumab in...

CPHI Sustainability Summit Targets Practical Pharma Action

CPHI Milan will host the inaugural CPHI Sustainability Summit...

Sterling Expands ADC Manufacturing Capacity and Capabilities

Contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions...
- Advertisement -

Eli Lilly and Company (NYSE: LLY) will attend the Morgan Stanley Global Healthcare Conference on Thursday, September 17, 2015. Sue Mahony, Ph.D., senior vice president and president of Lilly Oncology and Richard Gaynor, M.D., senior vice president of product development and medical affairs for Lilly Oncology, will participate in a fireside chat at 3:30 p.m., Eastern Daylight Time.

A live audio webcast will be available on the “Webcasts & Presentations” section of Lilly’s investor website at http://investor.lilly.com/events.cfm. A replay of the fireside chat will be available for approximately 90 days.

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast โ€“ stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Latest stories

Related stories

UCB Reports New EADV Data on Bimekizumab Treatment in HS

UCB has announced new three-year data for bimekizumab in...

CPHI Sustainability Summit Targets Practical Pharma Action

CPHI Milan will host the inaugural CPHI Sustainability Summit...

Sterling Expands ADC Manufacturing Capacity and Capabilities

Contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions...

eschbach Launches New Digital Leader Standard Work Capability for Pharma Process Operations

Seqonis Intelligent Operations by eschbach has a new dedicated...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป